Thyrotroph pituitary adenomas

Endocrinologist

Volumn 12, Issue 2, 2002, Pages 117-125

  Buchfelder, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODOACETIC ACID; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; THYROID HORMONE; THYROTROPIN;

ABDOMINAL DISCOMFORT; CHOLELITHIASIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEEDBACK SYSTEM; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; HYPOTHYROIDISM; REVIEW; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RESISTANCE; THYROTROPIN BLOOD LEVEL;

EID: 0036200438     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200203000-00010     Document Type: Review

References (75)

1. Regulation of thyrotropin secretion
2. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone: A new syndrome of inappropriate secretion of TSH
3. Inappropriate secretion of thyroid-stimulating hormone
4. Inappropriate secretion of thyrotropin by the pituitary
5. Hyperthyroidism due to thyrotropin-producing pituitary cheromophobe adenomas
6. TSH-sezernierende hypophysenadenome
7. Thyrotropin-secreting pituitary adenomas: Report of seven cases
8. A decade of pituitary microsurgery. The Herbert Olivecrona lecture
9. Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor
10. Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmus
11. Thyrotropin-secreting adenoma in an adolescent girl without increased serum thyrotropin-alpha
12. Thyrotropin-induced hyperthyroidism
13. MR1 of pituitary, hyperplasia in hypothyroidism
14. TSH-secreting pituitary adenomas
15. The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism
16. Thyrotropin-secreting pituitary adenomas: Clinical and biochemical heterogeneity
17. Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity and treatment outcome in 25 patients followed at the National Institute of Health
18. Variable biological activity of thyroid-stimulating hormone
19. Endocrine, biochemical and morphological studies of a pituitary adenoma secreting growth hormone, thyreotropin (TSH) and α-Subnit: Evidence for secretion of TSH with increase of bioactivity
20. TSH secreting pituitary adenoma: Case report, characterization of TSH and tumor cell perifusion
21. Thyrotropin-induced hyperthyroidism: Use of α- and β-subunit levels to identify patients with pituitary tumors
22. Thyrotropin-secreting pituitary tumors. Diagnostic and therapeutic considerations
23. Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma
24. A case of pituitary adenoma with possible simultaneous secretion of thyrotropin and follicle-stimulating hormone
25. Hyperthyroidism due to a rhyrotropin-secreting pituitary microadenoma
26. The syndromes of resistance to thyroid hormone
27. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associate with hyperthyroidism
28. Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma
29. Acromegaly and thyrotoxicosis induced by a GH- and TSH-producing pituitary tumour which also contained prolactin
30. Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH, alpha-subunit and GH
31. Hyperthyroidism due to a TSH secreting pituitary adenoma: Case report, treatment and evidence for adenoma TSH by morphological and cell culture studies
32. Somatostarin and thyrotropin-releasing hormone response and receptor status of a thyrotropin-secreting pituitary adenoma: Clinical and in vitro studies
33. Somatostarin receptors on thyrotropin-secreting pituitary adenomas: Comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretion
34. Combined thyrotroph and lactotroph cell hyperplasia simulating prolactin-secreting pituitary adenoma in longstanding hypothyroidism
35. Concomitant TSH and alpha-subunit secretion in 2 cases of successfully operated thyreotropinomas
36. Screening of candidate oncogenes in human thyrotroph tumors: Absence of activating mutations of the Gαq, Gα11, Gαs or thyrotropin-releasing hormone receptor gene
37. Proliferation parameters for pituitary adenomas
38. Thyroid-stimulating hormone pituitary adenomas and hyperthyroidism
39. Thyrotropin-secreting pituitary carcinoma
40. Clinical and immunohistochemical studies on TSH-secreting pituitary adenomas: Its multihormonality and expression of Pit-1
41. Anatomy and pathology of the thyrotrophs
42. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin
43. Pituitary adenomas with hyperfunction of TSH. Frequency, histological classification, immunocytochemistry and ultrastructure
44. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas
45. Surgical treatment of thyrotropin-secreting pituitary adenomas
46. Metabolic clearance and secretion rates of subunits of human thyrotropin
47. Hyperthyroidism due to a thyrotrophin-secreting microadenoma
48. Metabolic clearance and production rates of human thyrotropin
49. Clinical response of thyrotropin-secreting macroadenoma to bromocriptine and radiotherapy
50. Treatment of thyroid-stimulating hormone-secreting adenomas with octreotide
51. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue
52. TSH-secreting pituitary macroadenoma: Rapid tumor shrinkage and recovery from hyperthyroidism with octreotide
53. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide)
54. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog)
55. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog)
56. Octreotide acetate-induced size reduction of a large thyrotropin (TSH) secreting pituitary tumor with correction of hyperthyroidism and hypopituitarism
57. Reduction in size of a thyrotropin- and gonadotropin secreting pituitary adenoma treated with octreotide acetate (somatostatin analog)
58. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide
59. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog Lanreotide
60. Long-term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone secreting tumor
61. Large somatostatin-insensitive thyrotropin-secreting pituitary tumour responsive to Dethyroxine and dopamine-agonists
62. Resistance to thyroid hormones
63. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995
64. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone
65. Pituitary gland in hypothyroidism: Histologic and immunocytologic study
66. Regression of a pituitary adenoma following levothyroxine therapy of primary hypothyroidism
67. Volume of sella turcica in normal subjects and in patients with primary hypothyroidism and in hyperthyroidism
68. Pituitary hyperplasia due to hypothyroidism
69. Diminution of large pituitary tumor after replacement therapy for primary hypothyroidism
70. MR demonstration of pituitary hyperplasia and regression after therapy for hypothyroidism
71. Hyperthyroidism due to inappropriate secretion of Thyrotropin in 10 patients
72. MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy
73. Computer tomography of the pituitary fossa in primary hyperthyreodism. Effect of thyroxin treatment
74. Pituitary enlargement and primary hypothyroidism: A report of two cases with sharply contrasting outcomes